Improving Access to Care and Services

We collaborate with public and private sector organizations to expand access to care and services to improve global health.
Governments and private donors pledge US$812 million around five-day summit in Geneva; World Health Organization releases data showing medicines to prevent NTDs reach nearly a billion people each year
A reflection on our efforts to fight HIV, in Haiti and abroad, in honor of World AIDS Day 2014.
Lean more about the unique challenges associated with pediatric HIV in Haiti, following a recent trip to the country by Janssen medical colleagues.
A conversation about the New Horizons Advancing Pediatric HIV Treatment initiative, a drug donation program designed to expand access to our approved HIV medicines in sub-Saharan Africa.
Learn more about the New Horizons Advancing Pediatric HIV Treatment initiative.
Janssen announced a novel pediatric HIV treatment donation program free of charge for children and teens in eligible sub-Saharan African countries.
Learn more about how Johnson & Johnson is addressing the high rates of HIV infection in pregnant mothers and newborn babies.
World Vision launched a five-year Born On Time project in Ethiopia, the country’s first initiative to prioritize programs to prevent preterm birth.
While medical science has advanced leaps and bounds in recent generations, prematurity remains the top cause of newborn mortality in the United States. Learn more through this personal story.
Johnson & Johnson joins Born On Time: A Public-Private Partnership to Prevent Preterm Birth, the leading cause of death in children under age five.
World Vision CEO, Debbie Wolfe, explains how the Born on Time initiative is helping to eliminate the risk factors that can lead to pre-term birth in this Huffington Post blog.
PSI Impact reports on how Johnson & Johnson's MomConnect service has helped pregnant women in South African gain critical information about pregnancy via mobile phone.
Learn more about Johnson & Johnson’s Mom-Baby Messenger, a free text message service that provides important health information to pregnant women and mothers in China, via this Huffington Post blog.
The Helping Babies Breathe program trains health care professionals and mothers to use the latest technologies and safest practices to strengthen babies’ respiratory systems.
Timely interventions can help save lives. Learn more about Johnson & Johnson’s efforts to reach vulnerable women and babies in high-burden countries.
H4+ and Johnson & Johnson are giving doctors, midwives, and nurses the skills to give women hope for safe and healthy births.
Learn how Johnson & Johnson is connecting moms to quality health services to help eliminate threats to maternal health and survival.
Learn more about our vision of a world in which women, newborns and children can survive and thrive wherever they live.
Learn how skilled birth attendants, such as midwives, can help improve maternal and newborn health.
Learn more about the role of midwifery in improving maternal care and childbirth outcomes.
Learn how cross-sector collaboration is helping transform health for women, children and families.
Frontline health workers can directly impact survival rates. Learn how Johnson & Johnson’s is helping to expand the number of workers in the developing world.
Learn more about our mHealth program, which utilizes the power of text and voice messages to empower new and expectant mothers around the world.
Johnson & Johnson and its global partners, USAID, United Nations Foundation, mHealth Alliance and BabyCenter, share perspectives on the potential and power of mobile phones.
Learn about Johnson & Johnson’s commitment to improve the health of women and children in five key areas.
Devex reported on the formation of a partnership between Janssen and FIND to help step up the fight against TB, especially MDR-TB.
Janssen announced a novel collaboration with the non-profit organization FIND to provide increased access to molecular diagnostic tools for tuberculosis and MDR-TB case detection.
Georgia becomes the first country to receive free donations of SIRTURO® through Janssen and USAID partnership reports The Pharmaceutical Journal.
Intellectual Property Watch reports on the addition of Janssen's drug to help combat MDR-TB to the WHO Model List of Essential Medicines.
Janssen and USAID joined forces to step-up the fight against antibiotic-resistant bacteria, beginning with an estimated $30 million contribution of Janssen’s anti-MDR-TB treatment.
Johnson & Johnson donated doses of Janssen Pharmaceutical’s mebendazole for a school-based deworming program supported by Children Without Worms and the World Health Organization, targeting approximately 29 million children to treat soil-transmitted helminthiasis in Bangladesh.
The Ugandan Academy for Health Innovation and Impact, funded by Janssen, launched its five-year strategic plan, including the implementation of Connect for Life™.
We are committed to developing the tools needed to stop Ebola and help prevent the next epidemic.
SABC News interviews Lynda Toussaint, CEO of Unjani Clinics NPC, to discuss our recent partnership to improve the access and quality of primary healthcare available to low-income communities throughout South Africa.
India announces the anticipated introduction of SIRTURO® via
Learn more about Johnson & Johnson’s Mom-Baby Messenger, a free text message service that provides important health information to pregnant women and mothers in China, via this Huffington Post blog.
This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.